GSTM5
Basic information
Region (hg38): 1:109711780-109775428
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GSTM5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 12 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 12 | 2 | 4 |
Variants in GSTM5
This is a list of pathogenic ClinVar variants found in the GSTM5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-109712323-C-T | not specified | Likely benign (Nov 08, 2024) | ||
1-109712346-G-C | not specified | Uncertain significance (Aug 26, 2024) | ||
1-109712621-G-A | not specified | Uncertain significance (May 25, 2022) | ||
1-109713157-T-G | not specified | Uncertain significance (Dec 28, 2022) | ||
1-109713162-G-C | not specified | Uncertain significance (Jan 09, 2024) | ||
1-109713503-G-A | not specified | Uncertain significance (Sep 02, 2024) | ||
1-109713539-G-A | not specified | Uncertain significance (May 24, 2024) | ||
1-109713540-C-G | Benign (Apr 26, 2018) | |||
1-109713661-G-A | not specified | Uncertain significance (Oct 09, 2024) | ||
1-109713679-A-G | not specified | Uncertain significance (Nov 03, 2022) | ||
1-109713720-A-G | not specified | Uncertain significance (May 10, 2023) | ||
1-109714995-C-T | not specified | Uncertain significance (May 13, 2024) | ||
1-109715016-A-C | not specified | Uncertain significance (Oct 25, 2022) | ||
1-109715019-C-T | Benign (May 25, 2018) | |||
1-109715023-C-T | not specified | Uncertain significance (Oct 25, 2022) | ||
1-109715037-G-A | not specified | Uncertain significance (Feb 17, 2024) | ||
1-109715040-A-G | not specified | Uncertain significance (Apr 09, 2024) | ||
1-109715176-G-A | not specified | Uncertain significance (May 13, 2022) | ||
1-109715192-G-C | Benign (Jan 23, 2018) | |||
1-109715203-C-T | not specified | Uncertain significance (Jun 28, 2023) | ||
1-109715210-A-C | Likely benign (May 01, 2024) | |||
1-109715232-C-T | Likely benign (Dec 01, 2022) | |||
1-109717344-A-T | not specified | Uncertain significance (Jan 09, 2024) | ||
1-109717373-C-G | not specified | Uncertain significance (Dec 06, 2021) | ||
1-109717418-A-G | Benign (Aug 26, 2017) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GSTM5 | protein_coding | protein_coding | ENST00000256593 | 8 | 63187 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.19e-7 | 0.203 | 125640 | 0 | 108 | 125748 | 0.000430 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.944 | 148 | 119 | 1.24 | 0.00000684 | 1438 |
Missense in Polyphen | 31 | 32.226 | 0.96195 | 419 | ||
Synonymous | 0.128 | 42 | 43.1 | 0.975 | 0.00000221 | 378 |
Loss of Function | 0.188 | 11 | 11.7 | 0.941 | 5.09e-7 | 157 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00126 | 0.00126 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000164 | 0.000163 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000290 | 0.000290 |
Middle Eastern | 0.000164 | 0.000163 |
South Asian | 0.00124 | 0.00124 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. {ECO:0000269|PubMed:10587441}.;
- Pathway
- Glutathione metabolism - Homo sapiens (human);Hepatocellular carcinoma - Homo sapiens (human);Fluid shear stress and atherosclerosis - Homo sapiens (human);Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human);Drug metabolism - other enzymes - Homo sapiens (human);Drug metabolism - cytochrome P450 - Homo sapiens (human);Chemical carcinogenesis - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Nuclear Receptors Meta-Pathway;NRF2 pathway;Metapathway biotransformation Phase I and II;Glutathione conjugation;Phase II - Conjugation of compounds;glutathione-mediated detoxification;Biological oxidations;Metabolism
(Consensus)
Intolerance Scores
- loftool
- 0.863
- rvis_EVS
- 0.91
- rvis_percentile_EVS
- 89.44
Haploinsufficiency Scores
- pHI
- 0.0439
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.403
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.167
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gstm1
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- glutathione metabolic process;glutathione derivative biosynthetic process
- Cellular component
- cytosol;intercellular bridge
- Molecular function
- glutathione transferase activity;protein binding;identical protein binding